Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1960 2
1961 1
1962 1
1963 1
1964 2
1967 1
1969 1
1976 1
1979 1
1980 1
1981 3
1982 3
1983 1
1984 2
1985 1
1986 1
1987 5
1988 5
1989 5
1990 2
1991 5
1992 9
1993 5
1994 2
1995 3
1996 5
1997 7
1998 9
1999 5
2000 13
2001 3
2002 10
2003 6
2004 12
2005 18
2006 17
2007 13
2008 24
2009 30
2010 23
2011 28
2012 26
2013 33
2014 31
2015 22
2016 16
2017 25
2018 23
2019 18
2020 21
2021 15
2022 25
2023 20
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

511 results

Results by year

Filters applied: . Clear all
Page 1
An integrated organoid omics map extends modeling potential of kidney disease.
Lassé M, El Saghir J, Berthier CC, Eddy S, Fischer M, Laufer SD, Kylies D, Hutzfeldt A, Bonin LL, Dumoulin B, Menon R, Vega-Warner V, Eichinger F, Alakwaa F, Fermin D, Billing AM, Minakawa A, McCown PJ, Rose MP, Godfrey B, Meister E, Wiech T, Noriega M, Chrysopoulou M, Brandts P, Ju W, Reinhard L, Hoxha E, Grahammer F, Lindenmeyer MT, Huber TB, Schlüter H, Thiel S, Mariani LH, Puelles VG, Braun F, Kretzler M, Demir F, Harder JL, Rinschen MM. Lassé M, et al. Among authors: harder jl. Nat Commun. 2023 Aug 14;14(1):4903. doi: 10.1038/s41467-023-39740-7. Nat Commun. 2023. PMID: 37580326 Free PMC article.
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis.
Mariani LH, Eddy S, AlAkwaa FM, McCown PJ, Harder JL, Nair V, Eichinger F, Martini S, Ademola AD, Boima V, Reich HN, El Saghir J, Godfrey B, Ju W, Tanner EC, Vega-Warner V, Wys NL, Adler SG, Appel GB, Athavale A, Atkinson MA, Bagnasco SM, Barisoni L, Brown E, Cattran DC, Coppock GM, Dell KM, Derebail VK, Fervenza FC, Fornoni A, Gadegbeku CA, Gibson KL, Greenbaum LA, Hingorani SR, Hladunewich MA, Hodgin JB, Hogan MC, Holzman LB, Jefferson JA, Kaskel FJ, Kopp JB, Lafayette RA, Lemley KV, Lieske JC, Lin JJ, Menon R, Meyers KE, Nachman PH, Nast CC, O'Shaughnessy MM, Otto EA, Reidy KJ, Sambandam KK, Sedor JR, Sethna CB, Singer P, Srivastava T, Tran CL, Tuttle KR, Vento SM, Wang CS, Ojo AO, Adu D, Gipson DS, Trachtman H, Kretzler M. Mariani LH, et al. Among authors: harder jl. Kidney Int. 2023 Mar;103(3):565-579. doi: 10.1016/j.kint.2022.10.023. Epub 2022 Nov 25. Kidney Int. 2023. PMID: 36442540 Free PMC article.
Single cell transcriptomics identifies focal segmental glomerulosclerosis remission endothelial biomarker.
Menon R, Otto EA, Hoover P, Eddy S, Mariani L, Godfrey B, Berthier CC, Eichinger F, Subramanian L, Harder J, Ju W, Nair V, Larkina M, Naik AS, Luo J, Jain S, Sealfon R, Troyanskaya O, Hacohen N, Hodgin JB, Kretzler M, Kpmp KPMP; Nephrotic Syndrome Study Network (NEPTUNE). Menon R, et al. Among authors: harder j. JCI Insight. 2020 Mar 26;5(6):e133267. doi: 10.1172/jci.insight.133267. JCI Insight. 2020. PMID: 32107344 Free PMC article.
Human beta-defensin-2.
Schröder JM, Harder J. Schröder JM, et al. Among authors: harder j. Int J Biochem Cell Biol. 1999 Jun;31(6):645-51. doi: 10.1016/s1357-2725(99)00013-8. Int J Biochem Cell Biol. 1999. PMID: 10404637 Review.
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.
Rinke A, Müller HH, Schade-Brittinger C, Klose KJ, Barth P, Wied M, Mayer C, Aminossadati B, Pape UF, Bläker M, Harder J, Arnold C, Gress T, Arnold R; PROMID Study Group. Rinke A, et al. Among authors: harder j. J Clin Oncol. 2009 Oct 1;27(28):4656-63. doi: 10.1200/JCO.2009.22.8510. Epub 2009 Aug 24. J Clin Oncol. 2009. PMID: 19704057 Clinical Trial.
RNase 7 in Cutaneous Defense.
Rademacher F, Simanski M, Harder J. Rademacher F, et al. Among authors: harder j. Int J Mol Sci. 2016 Apr 14;17(4):560. doi: 10.3390/ijms17040560. Int J Mol Sci. 2016. PMID: 27089327 Free PMC article. Review.
Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19.
Robertson SJ, Bedard O, McNally KL, Shaia C, Clancy CS, Lewis M, Broeckel RM, Chiramel AI, Shannon JG, Sturdevant GL, Rosenke R, Anzick SL, Forte E, Preuss C, Baker CN, Harder JM, Brunton C, Munger S, Bruno DP, Lack JB, Leung JM, Shamsaddini A, Gardina P, Sturdevant DE, Sun J, Martens C, Holland SM, Rosenthal NA, Best SM. Robertson SJ, et al. Among authors: harder jm. Nat Commun. 2023 Jul 25;14(1):4481. doi: 10.1038/s41467-023-40076-5. Nat Commun. 2023. PMID: 37491352 Free PMC article.
Skin microbiota and human 3D skin models.
Rademacher F, Simanski M, Gläser R, Harder J. Rademacher F, et al. Among authors: harder j. Exp Dermatol. 2018 May;27(5):489-494. doi: 10.1111/exd.13517. Epub 2018 Apr 10. Exp Dermatol. 2018. PMID: 29464787 Review.
[Cholangiocarcinoma].
Harder J, Blum HE. Harder J, et al. Praxis (Bern 1994). 2002 Aug 21;91(34):1352-6. doi: 10.1024/0369-8394.91.34.1352. Praxis (Bern 1994). 2002. PMID: 12233266 Review. German.
511 results